
Small Cell Lung Cancer Survival Rates in 2026: What Stage-by-Stage Data Really Means & How New Immunotherapy Is Changing Outcomes
Small cell lung cancer survival rates range from 3% to 27% by stage — but 2026 immunotherapy breakthroughs are extending lives beyond what those numbers suggest. This guide explains every stage, what the survival data actually means for individual patients, and the newest treatment combinations giving oncologists real hope.


